Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.55
+0.09000.32%
Post-market: 28.580.0300+0.11%17:47 EDT
Volume:42.47M
Turnover:1.22B
Market Cap:162.33B
PE:37.57
High:29.09
Open:28.82
Low:28.47
Close:28.46
52wk High:29.09
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.24
T/O Rate:0.75%
Dividend:1.72
Dividend Rate:6.02%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.91
PE(LYR):20.93

Loading ...

Pfizer Canada Ulc: Perioperative Option Approved in Canada for Patients with Muscle-invasive Bladder Cancer Unable to Receive Cisplatin-based Therapy

THOMSON REUTERS
·
Jun 29

Pfizer Glp-1 Drug Passes Preliminary Review for China Medical Insurance Drug List - Official Statement

THOMSON REUTERS
·
Jun 29

Pfizer Balances Analyst Caution, Trial Shifts and CFO Exit

TIPRANKS
·
Jun 27

NYSE Most Active Issues

Dow Jones
·
Jun 27

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE) and Unicycive Therapeutics (UNCY)

TIPRANKS
·
Jun 27

Pfizer Halts Tafamidis Bioequivalence Study: What It Means for PFE Investors

TIPRANKS
·
Jun 27

Pfizer Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jun 26

Nanjing Leads Biolabs Co - Series B Round Led by Pfizer Ventures with Deep Track Capital, Gv, and Aditum Bio

THOMSON REUTERS
·
Jun 25

NYSE Most Active Issues

Dow Jones
·
Jun 25

Pfizer Keeps Quarterly Dividend at $0.43 per Share, Payable Sept. 1, to Shareholders of Record July 24

MT Newswires Live
·
Jun 25

Pfizer: Quarterly Cash Dividend of $0.43 Per Share

THOMSON REUTERS
·
Jun 25

Pfizer: Board of Directors Approves Quarterly Cash Dividend of $0.43 Per Share

THOMSON REUTERS
·
Jun 25

Press Release: Pfizer Declares Third-quarter 2026 Dividend

Dow Jones
·
Jun 25

Movement Alert|Pfizer Falls 3.03% in Regular Trading, Phase 3 Oncology Trial Failure Compounds CFO Departure Pressure

Market Focus
·
Jun 25

Pfizer Advances New Pediatric Pneumococcal “Catch-Up” Vaccine in Phase 3 Trial

TIPRANKS
·
Jun 25

FDA Approves Pfizer Inc's Palbociclib Combo for Hr-positive, Her2-positive Metastatic Breast Cancer Maintenance

Reuters
·
Jun 24

FDA approves Pfizer’s Ibrance combo for metastatic breast cancer

TIPRANKS
·
Jun 24

Pfizer Dismissed from US States' Drug Price-fixing Lawsuit

Reuters
·
Jun 24

Enanta Files Appeal in Ongoing Patent Dispute With Pfizer Over Paxlovid

MT Newswires Live
·
Jun 24